Loading organizations...
Loading organizations...
Key people at Invivo Capital.
Invivo Capital was founded by Ngozi Edozien (Founder and Managing Director).
Invivo Capital was founded by Ngozi Edozien (Founder and Managing Director).
Key people at Invivo Capital.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Sep 8, 2025 | Integra Therapeutics | $12.5M Pre-Series A | — | Advent France Biotechnology, CDTI, Columbus Venture Partners, Svetoslava Georgieva, Takeda Ventures |
| Sep 1, 2025 | ARTHEx Biotech | $41.0M Series B | Laurent Higueret | Advent Life Sciences, Alta Life Sciences, Sanofi Ventures, Ysios Capital, Advent France Biotechnology, CDTI Innvierte, José Antonio Mesa, European Innovation Council, Hadean Ventures, Sound Bioventures |
| Jan 8, 2025 | Neumirna Therapeutics | $23.3M Series A | Invivo Capital | — |
| Dec 12, 2023 | EsoBiotec | $2.2M Series A | Laura Rodríguez Gallego | — |
| Sep 1, 2023 | Corteria Pharmaceuticals | $70.0M Series A | Rafaèle Tordjman, Erez Chimovits | Caixa Capital, Faber, Kurma Partners, Roche Venture Fund, Sanofi Ventures, Fountain Healthcare Partners, Omnes Capital, V-Bio Ventures |
| Dec 2, 2021 | Integra Therapeutics | $5.1M Seed | — | Lluis Pareras, Miles Gerson, Matthieu Coutet |
| Jul 23, 2020 | ARTHEx Biotech | $4.9M Other Equity | — | Alain Huriez, Albert Ferrer |
